Takeda Pharmaceutical Company Limited
Patents, Design & Utilities
Last updated:
List of all Takeda Pharmaceutical Company Limited patents 339 in total
| Status | Patent |
|---|---|
Application | Utility: METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: PRODUCTION METHOD OF THIENOPYRIMIDINE DERIVATIVE Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Heterocyclic compound and application thereof Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Syringe Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: UTI FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Anti-plasma kallikrein antibodies Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Purification of factor VIII subspecies Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANTIBODY-RESIN COUPLING APPARATUS AND METHODS Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 |
Grant | Utility: Substituted piperidine compound and use thereof Filling date: 8 Sep 2025 Issue date: 5 Apr 2022 |
Application | Utility: PROPHYLACTIC OR THERAPEUTIC AGENT FOR DELIRIUM Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: CATIONIC LIPID Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: Treatment of CNS conditions Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: COMPOSITION FOR TREATING BLOOD COAGULATION AND/OR COMPLEMENT DISORDERS Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: HETEROCYCLIC COMPOUND AND USE THEREOF Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: T-CELL RECEPTOR MODIFIED OBJECT Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Heterocyclic compound and use thereof Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 |
Application | Utility: SUBCUTANEOUS ADMINISTRATION OF ADAMTS13 Filling date: 8 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF Filling date: 8 Sep 2025 Issue date: 17 Mar 2022 |
Grant | Utility: Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 |
Application | Utility: TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: ANTI-FACTOR IX PADUA ANTIBODIES Filling date: 8 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: ADAMTS13 protein cell culture supernatant Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: NOVEL ACTIVITY-BASED PROBES FOR NEUTROPHIL ELASTASE AND THEIR USE Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 |
Application | Utility: NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES Filling date: 8 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: DRUG DELIVERY SYSTEM USING SOLUTION Filling date: 8 Sep 2025 Issue date: 27 Jan 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Syringe Filling date: 8 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Pooling device for single or multiple medical containers Filling date: 8 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: ADAMTS13-CONTAINING COMPOSITIONS HAVING THROMBOLYTIC ACTIVITY Filling date: 8 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine Filling date: 8 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHODS OF TREATING ENDOMETRIOSIS Filling date: 8 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: SUBCUTANEOUS ADMINISTRATION OF ANTI-CD38 ANTIBODIES Filling date: 8 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: METHOD FOR ACTIVATION/PROLIFERATION OF T CELLS Filling date: 8 Sep 2025 Issue date: 9 Dec 2021 |
Application | Utility: HETEROCYCLIC COMPOUND Filling date: 8 Sep 2025 Issue date: 9 Dec 2021 |
Showing 50 to 100 of 339 patents.